Creative Medical (CELZ) news
Recent news
Creative Medical Technology - patent to extend IP protection for MyelocelZ platform in type 1 diabetes
Creative Medical Technology Holdings, Inc. (CELZ) has announced a development related to its intellectual property (IP) portfolio, specifically for its MyelocelZ platform, which is being explored for the treatment of type 1 diabetes. The company has taken steps to extend IP protection for this…
AInvest Wire · Aug 6, 2026Creative Medical Technology - receives USPTO notice of allowance for exosome-based Type 1 diabetes patent
AInvest Wire · Aug 6, 2026Creative Medical Technology Holdings announces agreements for exercise of warrants for $4.5 million gross proceeds
Creative Medical Technology Holdings, Inc. (Nasdaq: CELZ) has announced agreements with certain holders of its existing warrants for the immediate exercise of outstanding warrants to raise approximately $4.2 million in gross proceeds. The transaction involves the exercise of warrants to purchase up…
AInvest Wire · Jun 30, 2026Creative Medical Technology Holdings Inc. files to withdraw registration statement
AInvest Wire · Jun 30, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.